Table 2.
Sex, age, and medication at time of testing for FXS patients.
| Patient | Sex, age y | Psychoactive medication mg/d |
|---|---|---|
| FXS 1 | M, 20 | Abilify 2, Olanzapine 2.5, Zoloft 50 |
| FXS 2 | M, 40 | None |
| FXS 3 | M, 26 | None |
| FXS 4 | M, 18 | None |
| FXS 5 | F, 18 | None |
| FXS 6 | M, 35 | Venlafaxine 75, |
| FXS 7 | M, 28 | Quetiapine 50, Risperidone 2, Sertraline 50 |
| FXS 8 | M, 21 | None |
| FXS 9 | M, 26 | Sertraline 50 |
| FXS 10 | M, 26 | None |
| FXS 11 | M, 20 | None |
| FXS 12 | M, 27 | None |
| FXS 13 | M, 14 | Abilify 2, Adderal XR 40 |
| FXS 14 | M, 26 | Citalopram 40 |
| FXS 15 | M, 25 | None |
| FXS 16 | M, 24 | Sertraline 25, Quetiapine 25, Clonidine 0.1 |
| FXS 17 | F, 19 | None |
| FXS 18 | M, 35 | None |